跳至主要内容
临床试验/RPCEC00000401
RPCEC00000401已完成3 期

Abexol effect on indicators of oxidative stress and quality of life in middle-aged and older subjects - Abe/P-01

ational Centre for Scientific Research (CNIC)0 个研究点目标入组 50 人开始时间: 2022年3月20日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • Subjects who provided written informed consent for participating in the trial

排除标准

  • Patients with:
  • 1) Diagnosed thyroid
  • 2) Hepatic and/or renal diseases active
  • 3) Diagnosed cancer
  • 4) Uncontrolled diabetes (fasting glucose a head 7)
  • 5) Arterial hypertension (diastolic pressure a head 100 mmHg)
  • 6) Values of blood indicators: ALT or AST a head 55 UI, creatinine a head 130 umol/L
  • 7) Has suffered myocadial infarction, unstable angina, stroke, ATI, major surgery, within six months prior the study
  • 8) Consuming antioxidant supplements or vitamins within the last 4 weeks prior the trial

研究者

发起方
ational Centre for Scientific Research (CNIC)

相似试验